Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LiguaTSE:7090 +2.94%55 Debt-to-EBITDA is 4.26 as of Mar. 2026, which is 218% above its 10-year median of 1.34. GuruFocus rates TSE:7090 with a GF Score™ of 55/100 and a GF Value™ of 円892.32 (Fairly Valued). The stock has 3 warning signs investors should review. Among 482 Healthcare Providers & Services companies, Ligua ranks worse than 207468.67% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Ligua's Debt-to-EBITDA or its related term are showing as below:
TSE:7090'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1405.31 Med: 1.34 Max: 7.91
Current: -1405.31
During the past 9 years, the highest Debt-to-EBITDA Ratio of Ligua was 7.91. The lowest was -1405.31. And the median was 1.34.
TSE:7090's Debt-to-EBITDA is ranked worse than 100% of 482
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs TSE:7090: -1405.31
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Ligua Debt-to-EBITDA Related Terms
Ligua Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Ligua's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7090 vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Ligua's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ligua Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ligua's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ligua's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Ligua (TSE:7090) has a Debt-to-EBITDA of 4.26 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ligua. This is 218% above median its historical median of 1.34. According to the industry distribution chart, Ligua ranks #999999 out of 482 companies in the Healthcare Providers & Services industry.
Is Ligua's Debt-to-EBITDA too high?
Ligua's current Debt-to-EBITDA of 4.26 is 218% above median its 10-year median of 1.34. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Ligua's value of 4.26 is 95% above this industry median. Based on the distribution chart, Ligua ranks #999999 out of 482 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ligua has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ligua's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ligua ranks #999999 out of 482 companies for Debt-to-EBITDA. This places Ligua in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Ligua's value of 4.26 is 95% above this benchmark. While the company's 10-year median is 1.34 vs. the industry median of 2.19, Ligua has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 482 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ligua's current Debt-to-EBITDA of 4.26 is 95% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ligua. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ligua's current Debt-to-EBITDA is 4.26, which is 218% above median its own 10-year median of 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ligua stock overvalued right now?
Based on GuruFocus' analysis, Ligua (TSE:7090) is currently considered Fairly Valued. The stock's GF Value™ is 円892.32, compared to a current price of 円946.00 — trading 6% above its estimated fair value. The current Debt-to-EBITDA is 4.26, which is 218% above median its 10-year median of 1.34 and 95% above the Healthcare Providers & Services industry median of 2.19. Ligua's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Ligua (TSE:7090), the current Debt-to-EBITDA is 4.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ligua (TSE:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Ligua stock appears to be overvalued.
The current stock price of 円946.00 is trading 6% above its estimated GF Value™ of 円892.32.
GuruFocus considers Ligua to be Fairly Valued.
Key valuation signals for TSE:7090:
Debt-to-EBITDA: 4.26 (218% above median its 10-year median of 1.34)
GF Value™: 円892.32 vs. price of 円946.00 (6% above fair value)
Industry Position: 95% above the Healthcare Providers & Services median (#999999 of 482)
No single metric tells the full story. See the TSE:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ligua Inc is a consulting company providing management support to the healthcare industry for osteopaths. The company's services include sales office operations such as sales improvement, organizational management, executive education, and recruitment, to corporate management areas such as management of management figures and creation of business plans.
55GF Score
Get the complete analysis for TSE:7090
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7090 has been successfully added to your 
